03/27/2026
Want the SKINNY on Off-the-Shelf Fat? 💉
Dr Fearmonti breaks it down.
Autologous fat transfer, or harvesting your own fat through liposuction and re-injecting it to restore volume, remains the gold standard for biocompatible, natural results. However, not all patients are ideal candidates, and even in optimal cases, variability in fat survival (reported 30-70%) can present limitations. In the wake of massive weightloss trends and GLP-1 medications, patients now have limited donor sites. This has led to the development of advanced adipose-derived allograft technologies designed to enhance predictability and expand treatment options, in clinic and outside of the operating room.
Dr. Fearmonti has been an early adopter and national leader in fat grafting technologies, contributing to the refinement of techniques that optimize safety, viability, and long-term outcomes.
Alloclae™ is among the newest innovations in this category of structural adipose allografts. Designed with advanced processing techniques, Alloclae preserves key architectural and biochemical components of adipose tissue, enabling it to function as both a volumizing agent and a biologically active scaffold. Clinically, Alloclae is particularly valuable in areas requiring more robust structural support, such as hip dips, cellulite deformities, and complex contour irregularities. Due to its large particle size and other factors, it is currently only used in the body, not the face (Renuva and Lipoderma excel here). Available in 12.5 and 25 cc aliquots, it can provide large volume enhancement or replacement. Its ability to integrate with host tissue while maintaining shape and consistency makes it a powerful tool for both primary aesthetic enhancement and revision procedures.
Check out our blog to get the SKINNY on Alloclae™, Renuva® (allograft adipose matrix) and Lipoderma®.
https://www.alonaesthetics.com/post/allograft-fat